glp-1 receptor agonist and dpp-4 inhibitor combination contraindicated Table 2 from DPP- 4 Inhibitors in the Management of Type 2 Diabetes Mellitus GLP-1-RA and DPP-4 inhibitors in

An endogenous uncoupling and swelling agent in liver mitochondria and its enzymic formation

Development of an amperometric biosensor based on glutathione peroxidase immobilized in a carbodiimide matrix for the analysis of reduced glutathione from serum

Some gastroenterologists have prescribed GLP-1 receptor agonists to patients with well-controlled IBD, particularly when metabolic benefits outweigh theoretical risks

Effects of N-acetylcysteine amide (NACA), a novel thiol antioxidant against glutamate-induced cytotoxicity in neuronal cell line PC12

More extensive human trials are needed to confirm these preclinical observations, establish optimal dosing, and fully understand its safety profile